Update date
31 Dec 2020
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported noncurrent liabilities: CA$6,883,461. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2020
Page type
Metric history
Latest period
Q4 2020
SEC-backed company facts were refreshed from filings filed on 13 Nov 2026.
Benchmark Context
ONCOLYTICS BIOTECH INC sits in the upper half of the current noncurrent liabilities sample.
Compared with
Compared with 4 companies reporting noncurrent liabilities in CAD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 1x the current sample midpoint. Noncurrent Liabilities is roughly flat versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Financial Metric Page
Latest period: Q4 2020. Period end: 31 Dec 2020. Units: CAD. Frequency: quarterly.
Noncurrent Liabilities is reported in company XBRL facts filed with the SEC.
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Noncurrent Liabilities levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
ONCOLYTICS BIOTECH INC appears at rank #2 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | Versus Systems Inc. (vs) | CA$8,610,395 | Instant - 31 Dec 2020 | Open Versus Systems Inc. Noncurrent Liabilities |
| 2 | ONCOLYTICS BIOTECH INC (oncy) | CA$6,883,461 | Instant - 31 Dec 2020 | Open ONCOLYTICS BIOTECH INC Noncurrent Liabilities |
| 3 | ADURO CLEAN TECHNOLOGIES INC. (adur) | CA$513,385 | Instant - 31 May 2025 | Open ADURO CLEAN TECHNOLOGIES INC. Noncurrent Liabilities |
| 4 | BriaCell Therapeutics Corp. (bctx) | CA$191,572 | Instant - 31 Jul 2020 | Open BriaCell Therapeutics Corp. Noncurrent Liabilities |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2020 | CA$6,883,461 | -CA$13,255 | -0.19% | 31 Dec 2020 | 20-F | 05 Mar 2021 | 2020 | FY |
| Q4 2019 | CA$6,896,716 | +CA$1,041,401 | +18% | 31 Dec 2019 | 20-F | 05 Mar 2021 | 2020 | FY |
| Q4 2018 | CA$5,855,315 | +CA$1,218,380 | +26% | 31 Dec 2018 | 20-F | 06 Mar 2020 | 2019 | FY |
| Q4 2017 | CA$4,636,935 | +CA$4,636,935 | 31 Dec 2017 | 20-F | 15 Mar 2019 | 2018 | FY | |
| Q4 2016 | CA$0 | 31 Dec 2016 | 20-F | 19 Mar 2018 | 2017 | FY |